Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cancel

BSE Code : 500087 | NSE Symbol : CIPLA | ISIN : INE059A01026 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

(14-May-25 15:08) Cipla to convene AGM
(13-May-25 15:17) Cipla registers PAT of Rs 1,222 crore in Q4; EBITDA margin rises to 22.8%
(13-May-25 14:34) Board of Cipla recommends special dividend
(13-May-25 14:34) Board of Cipla recommends final dividend
(13-May-25 14:14) Cipla consolidated net profit rises 30.12% in the March 2025 quarter
(13-May-25 13:47) Cipla fixes record date for final dividend
(21-Apr-25 11:32) Cipla’s Goa API facility receives VAI status from USFDA
(17-Apr-25 16:12) Cipla allots 23,282 equity shares under ESOS
(11-Apr-25 10:12) Cipla jumps on receiving approval from USFDA for protein-bound Paclitaxel
(11-Apr-25 09:27) Cipla receives USFDA approval for Protein-bound Paclitaxel for Injectable Suspension

1 2 3 4 5 6 7 8 9 10

Cipla Ltd